These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Heart Failure in Relation to Anthracyclines and Other Chemotherapies. Agunbiade TA; Zaghlol RY; Barac A Methodist Debakey Cardiovasc J; 2019; 15(4):243-249. PubMed ID: 31988684 [TBL] [Abstract][Full Text] [Related]
4. Clinical spectrum of anthracycline antibiotic cardiotoxicity. Bristow MR; Billingham ME; Mason JW; Daniels JR Cancer Treat Rep; 1978 Jun; 62(6):873-9. PubMed ID: 667861 [TBL] [Abstract][Full Text] [Related]
5. Cardiac Toxicity: Using Angiotensin-Converting Enzyme Inhibitors to Prevent Anthracycline-Induced Left Ventricular Dysfunction and Cardiomyopathy. Kobza C Clin J Oncol Nurs; 2021 Jun; 25(3):259-266. PubMed ID: 34019025 [TBL] [Abstract][Full Text] [Related]
6. Medical interventions for treating anthracycline-induced symptomatic and asymptomatic cardiotoxicity during and after treatment for childhood cancer. Sieswerda E; van Dalen EC; Postma A; Cheuk DK; Caron HN; Kremer LC Cochrane Database Syst Rev; 2011 Sep; (9):CD008011. PubMed ID: 21901716 [TBL] [Abstract][Full Text] [Related]
7. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. Pai VB; Nahata MC Drug Saf; 2000 Apr; 22(4):263-302. PubMed ID: 10789823 [TBL] [Abstract][Full Text] [Related]
8. [Early detection of cancer therapeutics-related cardiac dysfunction]. Potier A; Ederhy S; Ancedy Y; Etienney A; Soulat-Dufour L; Chauvet M; Hollebecque A; Adavane-Scheuble S; Boccara F; Soria JC; Cohen A Bull Cancer; 2016; 103(7-8):667-73. PubMed ID: 27417336 [TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of anthracycline cardiotoxicity. Mele D; Tocchetti CG; Pagliaro P; Madonna R; Novo G; Pepe A; Zito C; Maurea N; Spallarossa P J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e3-e11. PubMed ID: 27755237 [TBL] [Abstract][Full Text] [Related]
10. [Cardiotoxicity as undesired side effect in the treatment of breast cancer]. Gramatyka M Postepy Hig Med Dosw (Online); 2014 May; 68():483-97. PubMed ID: 24864100 [TBL] [Abstract][Full Text] [Related]
11. Anthracycline-induced cardiotoxicity in children with cancer: strategies for prevention and management. Iarussi D; Indolfi P; Casale F; Martino V; Di Tullio MT; Calabrò R Paediatr Drugs; 2005; 7(2):67-76. PubMed ID: 15871628 [TBL] [Abstract][Full Text] [Related]
13. Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk. Barrett-Lee PJ; Dixon JM; Farrell C; Jones A; Leonard R; Murray N; Palmieri C; Plummer CJ; Stanley A; Verrill MW Ann Oncol; 2009 May; 20(5):816-27. PubMed ID: 19153118 [TBL] [Abstract][Full Text] [Related]